4-(4-(4-acetamido-1-methyl-1H-pyrrole-2-carboxamido)-1-methyl-1H-pyrrole-2-carboxamido)-N-(2-(3-(2-(4-(5-(5-(3-(5-(2-(5-(3-(3-(dimethylamino)propylamino)-3-oxopropylcarbamoyl)-1-methyl-1H-pyrrol-3-ylcarbamoyl)-1-methyl-1H-imidazol-4-ylcarbamoyl)-1-methyl-1H-pyrrol-3-ylamino)-3-oxopropylcarbamoyl)-1-methyl-1H-pyrrol-3-ylcarbamoyl)-1-methyl-1H-pyrrol-3-ylamino)-4-oxobutylcarbamoyl)-1-methyl-1H-imidazol-4-ylamino)-3-oxopropylcarbamoyl)-1-methyl-1H-imidazol-4-yl)-1-methyl-1H-imidazole-2-carboxamide hydrochloride

ID: ALA5268128

Chembl Id: CHEMBL5268128

Max Phase: Preclinical

Molecular Formula: C88H107ClN34O17

Molecular Weight: 1912.04

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)Nc1cc(C(=O)Nc2cc(C(=O)Nc3cc(C(=O)Nc4cn(C)c(C(=O)Nc5cn(C)c(C(=O)NCCC(=O)Nc6cn(C)c(C(=O)NCCCC(=O)Nc7cc(C(=O)Nc8cc(C(=O)Nc9cc(C(=O)NCCC(=O)Nc%10cc(C(=O)Nc%11cn(C)c(C(=O)Nc%12cc(C(=O)NCCC(=O)NCCCN(C)C)n(C)c%12)n%11)n(C)c%10)n(C)c9)n(C)c8)n(C)c7)n6)n5)n4)n(C)c3)n(C)c2)n(C)c1.Cl

Standard InChI:  InChI=1S/C88H106N34O17.ClH/c1-48(123)94-49-28-59(113(6)36-49)79(130)98-53-33-62(117(10)40-53)82(133)100-55-35-64(118(11)42-55)84(135)108-67-46-122(15)76(106-67)88(139)109-68-47-120(13)74(104-68)86(137)93-26-21-72(127)102-65-44-119(12)73(103-65)85(136)90-22-16-18-70(125)95-50-29-60(114(7)37-50)80(131)99-54-34-61(116(9)41-54)81(132)97-52-31-57(111(4)39-52)78(129)92-25-20-71(126)96-51-30-63(115(8)38-51)83(134)107-66-45-121(14)75(105-66)87(138)101-56-32-58(112(5)43-56)77(128)91-24-19-69(124)89-23-17-27-110(2)3;/h28-47H,16-27H2,1-15H3,(H,89,124)(H,90,136)(H,91,128)(H,92,129)(H,93,137)(H,94,123)(H,95,125)(H,96,126)(H,97,132)(H,98,130)(H,99,131)(H,100,133)(H,101,138)(H,102,127)(H,107,134)(H,108,135)(H,109,139);1H

Standard InChI Key:  CITZMMPSHBVHJR-UHFFFAOYSA-N

Associated Targets(Human)

dsDNA (365 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC827 (1172 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MRC5 (9203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1912.04Molecular Weight (Monoisotopic): 1910.8475AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Wang M, Ma X, Zhou K, Mao H, Liu J, Xiong X, Zhao X, Narva S, Tanaka Y, Wu Y, Guo C, Sugiyama H, Zhang W..  (2021)  Discovery of Pyrrole-imidazole Polyamides as PD-L1 Expression Inhibitors and Their Anticancer Activity via Immune and Nonimmune Pathways.,  64  (9.0): [PMID:33949196] [10.1021/acs.jmedchem.1c00120]

Source